Healthcare provider profile · identity verified

Jane A Fleagle, MD

Internal Medicine · ATHENS, GA · NPI 1396704029

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	789	228
Amlodipine Besylate	Amlodipine Besylate	604	184
Levothyroxine Sodium	Levothyroxine Sodium	440	113
Losartan Potassium	Losartan Potassium	307	102
Omeprazole	Omeprazole	285	79
Rosuvastatin Calcium	Rosuvastatin Calcium	270	84
Lisinopril	Lisinopril	269	73
Gabapentin	Gabapentin	268	65
Famotidine	Famotidine	224	76
Alendronate Sodium	Alendronate Sodium	222	72
Sertraline Hcl	Sertraline Hcl	201	59
Ozempic	Semaglutide	199	31
Hydrochlorothiazide	Hydrochlorothiazide	196	61
Metformin Hcl Er	Metformin Hcl	191	55
Pravastatin Sodium	Pravastatin Sodium	186	53
Trazodone Hcl	Trazodone Hcl	167	52
Atenolol	Atenolol	159	44
Pantoprazole Sodium	Pantoprazole Sodium	152	53
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	151	41
Metoprolol Succinate	Metoprolol Succinate	142	38
Escitalopram Oxalate	Escitalopram Oxalate	141	43
Potassium Chloride	Potassium Chloride	126	43
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	125	37
Fluticasone Propionate	Fluticasone Propionate	122	52
Fluoxetine Hcl	Fluoxetine Hcl	111	35
Tramadol Hcl	Tramadol Hcl	110	34
Valsartan	Valsartan	109	35
Metformin Hcl	Metformin Hcl	108	35
Allopurinol	Allopurinol	93	25
Buspirone Hcl	Buspirone Hcl	88	28
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	87	30
Eliquis	Apixaban	86	21
Nifedipine Er	Nifedipine	85	21
Spironolactone	Spironolactone	81	25
Montelukast Sodium	Montelukast Sodium	80	23
Zolpidem Tartrate	Zolpidem Tartrate	75	23
Meloxicam	Meloxicam	74	24
Albuterol Sulfate Hfa	Albuterol Sulfate	72	38
Hydralazine Hcl	Hydralazine Hcl	72	23
Venlafaxine Hcl Er	Venlafaxine Hcl	70	20
Mirtazapine	Mirtazapine	67	17
Carvedilol	Carvedilol	64	21
Furosemide	Furosemide	64	22
Doxycycline Hyclate	Doxycycline Hyclate	60	52
Januvia	Sitagliptin Phosphate	59	14
Ezetimibe	Ezetimibe	58	17
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	57	20
Duloxetine Hcl	Duloxetine Hcl	56	14
Alprazolam	Alprazolam	54	15
Simvastatin	Simvastatin	53	16
Citalopram Hbr	Citalopram Hydrobromide	52	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	50	17
Jardiance	Empagliflozin	47	15
Trulicity	Dulaglutide	46	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	16
Prednisone	Prednisone	44	39
Fenofibrate	Fenofibrate	43	13
Klor-Con M20	Potassium Chloride	43	19
Azelastine Hcl	Azelastine Hcl	42	19
Cephalexin	Cephalexin	42	35
Bupropion Xl	Bupropion Hcl	38	14
Synthroid	Levothyroxine Sodium	38	suppressed
Estradiol	Estradiol	36	15
Memantine Hcl	Memantine Hcl	34	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	34	11
Glipizide	Glipizide	33	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Mounjaro	Tirzepatide	31	suppressed
Donepezil Hcl	Donepezil Hcl	30	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	30	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Amoxicillin	Amoxicillin	28	21
Clopidogrel	Clopidogrel Bisulfate	28	11
Triamcinolone Acetonide	Triamcinolone Acetonide	28	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Indapamide	Indapamide	27	suppressed
Ipratropium Bromide	Ipratropium Bromide	27	11
Clonidine Hcl	Clonidine Hcl	26	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	26	suppressed
Myrbetriq	Mirabegron	26	suppressed
Valacyclovir	Valacyclovir Hcl	25	12
Clonazepam	Clonazepam	24	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	19
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Xarelto	Rivaroxaban	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Novolin R	Insulin Regular, Human	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	21	21
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Sucralfate	Sucralfate	20	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	19	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	12
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Lorazepam	Lorazepam	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Victoza 3-Pak	Liraglutide	18	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	17	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Fluconazole	Fluconazole	16	13
Felodipine Er	Felodipine	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Naltrexone Hcl	Naltrexone Hcl	14	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	14	14
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Azithromycin	Azithromycin	12	12
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	12	suppressed
Methimazole	Methimazole	12	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error